G6PDH Quantitative Test in Lahore at Lahore PCR Lab

G6PDH (Quantitative) at Lahore PCR Lab

The Glucose-6-Phosphate Dehydrogenase (G6PDH) Quantitative Test is a specialized diagnostic laboratory investigation designed to measure the precise enzymatic activity of G6PD in red blood cells. G6PD is a critical cytosolic enzyme that plays a pivotal role in the hexose monophosphate (HMP) shunt, an auxiliary pathway of glucose metabolism. This pathway is the sole source of reduced nicotinamide adenine dinucleotide phosphate (NADPH) in mature erythrocytes. NADPH is essential for maintaining glutathione in its reduced state, which in turn protects red blood cells from oxidative damage caused by free radicals, reactive oxygen species, and oxidative drugs. When an individual has a G6PD deficiency, their red blood cells are highly susceptible to premature destruction, leading to acute or chronic hemolytic anemia. Lahore PCR Lab, located in Lahore, Pakistan, offers this high-precision quantitative assay to help clinicians accurately evaluate enzyme levels, identify deficiencies, and guide safe therapeutic interventions.

Unlike qualitative screening tests that merely indicate the presence or absence of the enzyme above a certain threshold, the quantitative G6PD assay provides an exact measurement of enzyme activity, typically expressed in units per gram of hemoglobin (U/g Hb). This level of precision is clinically vital, particularly for identifying heterozygous female carriers who exhibit variable enzyme activity due to random X-chromosome inactivation (lyonization). By utilizing advanced spectrophotometric technology, Lahore PCR Lab ensures that patients receive highly accurate, reproducible, and clinically validated results. This test is of paramount importance in regions like Pakistan, where genetic variations and hereditary enzymopathies are relatively common, and where malaria treatments involving oxidative drugs are frequently prescribed.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure the clinical accuracy of the quantitative G6PDH test. Patients must adhere to the following guidelines prior to sample collection:

• Avoid Testing During Acute Hemolytic Episodes: The test should ideally not be performed during or immediately after an acute hemolytic crisis. During hemolysis, older red blood cells (which have the lowest enzyme levels) are destroyed first, leaving behind a younger population of reticulocytes. Because reticulocytes contain higher levels of G6PD, testing during this period can produce a false-normal result. It is clinically recommended to wait 2 to 3 months after an acute episode has resolved before undergoing quantitative testing.
• Postpone Testing After Blood Transfusions: If you have recently received a blood transfusion, you must wait at least 3 months before taking this test. Transfused donor red blood cells will temporarily mask your true G6PD enzyme activity, leading to inaccurate results.
• Medication Review: Inform your prescribing physician and the laboratory staff at Lahore PCR Lab of all medications, supplements, and herbal remedies you are currently taking. Certain oxidative drugs, such as antimalarials (primaquine), sulfonamides, and high-dose vitamin C, should be reviewed, as they can precipitate hemolysis and affect clinical interpretation.
• No Fasting Required: Standard dietary fasting is not required for this blood test. You may eat and drink normally prior to your appointment, unless instructed otherwise by your physician for concurrent tests.
• Hydration: Ensure you are well-hydrated, as this makes venipuncture easier and helps secure a high-quality whole blood sample.

During the Procedure

The quantitative G6PDH test is performed on a peripheral whole blood sample. The collection process at Lahore PCR Lab is designed to be quick, safe, and minimally invasive:

• Patient Positioning: You will be asked to sit comfortably in a blood collection chair. The phlebotomist will position your arm on a supportive armrest.
• Site Selection and Sanitization: The phlebotomist will locate a suitable vein, typically in the antecubital fossa (the crook of the elbow). The skin over the selected vein is thoroughly cleansed with an antiseptic swab (usually 70% isopropyl alcohol) and allowed to air dry to prevent contamination.
• Tourniquet Application: A sterile elastic tourniquet is applied around your upper arm to temporarily restrict venous blood flow, causing the veins to swell and become more visible and accessible.
• Venipuncture: A sterile, single-use, fine-gauge needle attached to a vacuum collection tube (typically containing EDTA as an anticoagulant) is gently inserted into the vein. You may feel a brief pinch or stinging sensation as the needle enters the skin.
• Sample Collection: Blood is drawn into the collection tube. The quantitative assay requires a specific volume of whole blood to ensure an accurate ratio of enzyme activity to hemoglobin concentration.
• Tourniquet and Needle Removal: Once the required volume of blood is collected, the tourniquet is released, and the needle is gently withdrawn.
• Post-Puncture Care: Immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to promote hemostasis. A small adhesive bandage is then applied to keep the site clean and prevent minor bleeding.
• Duration and Safety: The entire venipuncture procedure takes less than five minutes. All equipment used at Lahore PCR Lab is sterile and disposable, completely eliminating any risk of cross-contamination.

When is a G6PDH (Quantitative) Performed?

Screening Before Oxidative Drug Therapy

Physicians routinely request a quantitative G6PDH test before initiating treatment with medications known to induce oxidative stress in red blood cells. Key drugs include antimalarials like primaquine and tafenoquine, sulfones such as dapsone, certain sulfonamide antibiotics, nitrofurantoin, and rasburicase. Administering these agents to a G6PD-deficient individual can trigger severe, life-threatening acute intravascular hemolysis. Quantitative testing at Lahore PCR Lab ensures that clinicians can safely prescribe these essential therapies or select alternative medications if a deficiency is detected.

Investigating Unexplained Neonatal Jaundice

Neonatal hyperbilirubinemia is a common condition, but when it is unusually severe, prolonged, or fails to respond to standard phototherapy, G6PD deficiency must be suspected. Pediatricians order this test for newborns exhibiting rapid rises in indirect bilirubin levels within the first 24 to 48 hours of life. Early detection of G6PD deficiency in neonates is critical to preventing bilirubin-induced neurologic dysfunction (BIND) and kernicterus, a permanent form of brain damage caused by excessive bilirubin accumulation in brain tissues.

Evaluating Acute Hemolytic Anemia Episodes

When a patient presents with sudden symptoms of hemolysis—such as dark, tea-colored urine, rapid-onset pale skin, fatigue, and scleral icterus (yellowing of the eyes)—physicians must identify the underlying trigger. These acute episodes are often precipitated by infections (viral or bacterial), diabetic ketoacidosis, or exposure to specific chemical agents. A quantitative G6PD assay helps determine if an underlying hereditary enzyme deficiency is the primary predisposing factor for the hemolytic crisis.

Investigating Favism Symptoms

Favism is a clinical syndrome characterized by severe hemolytic anemia following the ingestion of fava beans (Vicia faba) or inhalation of pollen from the fava plant. Fava beans contain vicine and convicine, glucosides that undergo metabolism to produce highly reactive divicine and isouramil, which exert massive oxidative stress on erythrocytes. If a patient, particularly a young child, develops acute illness after consuming fava beans, a quantitative G6PD test is performed to confirm the diagnosis of favism.

Family History and Genetic Carrier Screening

Because G6PD deficiency is an X-linked recessive genetic disorder, it primarily affects males, while females are typically carriers. However, due to skewed X-chromosome inactivation, some female carriers can have significantly reduced enzyme levels and experience clinical symptoms. Genetic counseling and family screening are common indications for this test. If a family member is diagnosed with G6PD deficiency, relatives—especially females of childbearing age—may undergo quantitative testing at Lahore PCR Lab to assess their carrier status and understand potential risks for future offspring.

What Does a G6PDH (Quantitative) Detect?

The quantitative G6PDH test is a highly sensitive diagnostic tool that provides comprehensive insights into erythrocyte biochemistry and metabolic integrity. Specifically, this assay detects and quantifies:

• Severe G6PD Deficiency (Class I and II): Identifies patients with critically low enzyme activity (often less than 10% of normal levels), who are at high risk for chronic nonspherocytic hemolytic anemia or severe acute hemolytic crises.
• Moderate to Mild Deficiency (Class III): Detects individuals with 10% to 60% of normal enzyme activity, who are typically asymptomatic under baseline conditions but can develop acute hemolysis when exposed to oxidative drugs, infections, or fava beans.
• Heterozygous Female Carrier Status: Quantifies intermediate enzyme levels in females, helping to identify carriers who may have borderline or low-normal activity and could still be susceptible to drug-induced hemolysis.
• Normal Enzymatic Activity (Class IV): Confirms adequate G6PD enzyme levels, indicating that the patient can safely tolerate standard therapeutic doses of oxidative medications.
• Increased Enzyme Activity (Class V): Detects abnormally high G6PD levels, which can occur in states of marked reticulocytosis (such as recovery from a hemolytic episode or hemorrhage) because young red blood cells naturally possess higher enzyme concentrations.
• Susceptibility to Drug-Induced Hemolysis: Identifies patients who must avoid specific pharmacological agents to prevent acute hemolytic anemia.
• Susceptibility to Infection-Induced Hemolysis: Helps clinicians understand why a patient experienced sudden anemia during a common viral or bacterial infection.
• Etiology of Neonatal Hyperbilirubinemia: Pinpoints G6PD deficiency as the root cause of severe newborn jaundice, allowing for immediate clinical intervention.
• Etiology of Favism: Confirms the metabolic basis for severe hemolytic reactions following the consumption of fava beans.
• Erythrocyte Metabolic Integrity: Assesses the overall health and antioxidant defense capacity of the patient’s red blood cell population.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making. The G6PDH (Quantitative) test is processed using automated, state-of-the-art spectrophotometric analyzers that undergo rigorous daily quality control. Typically, verified test reports are completed and authorized by our consultant pathologists within 24 to 48 hours of sample collection.

Patients and referring physicians can access reports conveniently through multiple channels. Once the report is finalized, an automated SMS notification containing a secure link is sent directly to the patient’s registered mobile number. Reports can be viewed, downloaded, and printed online via the official Lahore PCR Lab web portal. Physical copies of the reports can also be collected directly from our main diagnostic center or designated collection points across Lahore.

G6PDH (Quantitative) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
G6PD Enzyme Activity (Adults)	7.0 – 20.5 U/g Hb (Reference ranges may vary slightly by age and laboratory instrumentation)	< 10% of normal (Severe deficiency); 10% – 60% of normal (Moderate/mild deficiency)
G6PD Enzyme Activity (Neonates)	Typically higher than adult ranges due to younger RBC population	Significantly reduced levels indicating congenital G6PD deficiency
Hemoglobin (Hb) Levels	Male: 13.8 – 17.2 g/dL; Female: 12.1 – 15.1 g/dL	Decreased levels during hemolytic episodes (Anemia)
Reticulocyte Count	0.5% – 2.5% of total red blood cells	Elevated counts (> 2.5%) indicating compensatory bone marrow response to hemolysis
Serum Bilirubin (Total & Indirect)	Total: 0.2 – 1.2 mg/dL; Indirect: < 0.8 mg/dL	Elevated indirect bilirubin indicating active hemolysis or neonatal jaundice
Serum Haptoglobin	30 – 200 mg/dL	Markedly decreased or undetectable levels during intravascular hemolysis
Lactate Dehydrogenase (LDH)	140 – 280 U/L	Elevated levels indicating red blood cell lysis and tissue hypoxemia
Heinz Bodies (Peripheral Blood Smear)	Absent	Present during acute oxidative stress, representing denatured hemoglobin

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for G6PDH (Quantitative)?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, clinical biochemists, and experienced phlebotomists who ensure the highest standards of diagnostic accuracy.
• Patient-Focused Care: We prioritize patient comfort and safety, providing a compassionate and professional environment during sample collection and testing.
• Quality Diagnostic Services: Lahore PCR Lab utilizes advanced spectrophotometric assays and automated analyzers to deliver highly precise quantitative enzyme measurements.
• Professional Reporting: All diagnostic reports undergo a multi-level verification process by senior pathologists to guarantee clinical reliability.
• Modern Diagnostic Approach: We employ state-of-the-art laboratory technology and adhere to international quality control guidelines (EQAS) for all specialized chemistry assays.
• Comfortable Environment: Our modern diagnostic facility in Lahore is designed to offer a clean, hygienic, and stress-free experience for patients of all ages.
• Convenient Location: Strategically located in Lahore, our center and collection points are easily accessible to patients from all parts of the city.
• Commitment to Accurate Diagnosis: We are dedicated to providing timely, evidence-based diagnostic insights that empower clinicians to make informed treatment decisions.